JPMorgan analyst Richard Vosser raised the firm’s price target on Novartis to CHF 95 from CHF 90 and keeps a Neutral rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVS:
